These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2081917)

  • 1. Aneuploid DNA content in pancreatic adenocarcinoma.
    Wido TM; Myles JL; Pisharodi L; Sawyer T; Kim K; Gohara AF; Howard JM
    Int J Pancreatol; 1990; 7(1-3):129-34. PubMed ID: 2081917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear DNA content as a prognostic predictor in carcinoma of the pancreas.
    Yoshimura T; Manabe T; Suwa H; Imamura T; Wang Z; Ohshio G; Yamabe H; Matsumoto M; Ogasahara K; Takasan H
    Int J Pancreatol; 1993 Aug; 14(1):29-36. PubMed ID: 8409574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
    Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of analysis of DNA in pancreatic adenocarcinoma by flow cytometry.
    Hyöty M; Visakorpi T; Kallioniemi OP; Mattila J; Laippala P; Nordback I
    Eur J Surg; 1991 Oct; 157(10):595-600. PubMed ID: 1687251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of flow cytometric DNA analysis in determining prognosis of resectable ductal adenocarcinoma of the pancreas.
    Park CS; Wiebke EA; Sidner RA; Miller GA; Cummings OW; Howard TJ; Fineberg NS; Madura JA
    Am Surg; 1996 Jul; 62(7):609-15; discussion 615-6. PubMed ID: 8651561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical significance of nuclear DNA content measurements in pancreatic neoplasms and their Kaplan-Meier survival analysis].
    Sun CY; Zhang YL; Chao SL
    Zhonghua Wai Ke Za Zhi; 1994 Jun; 32(6):364-6. PubMed ID: 7842963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA aneuploidy is an independent factor of poor prognosis in pancreatic and peripancreatic cancer.
    Sciallero S; Giaretti W; Geido E; Bonelli L; Zhankui L; Saccomanno S; Zeraschi E; Pugliese V
    Int J Pancreatol; 1993 Aug; 14(1):21-8. PubMed ID: 8409573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of cellular ploidy in adenocarcinoma of the middle rectum].
    Tomaini D; Cataldi M; Ferrario D; Giudici C
    Pathologica; 1992; 84(1090):165-70. PubMed ID: 1437305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic adenocarcinoma of unknown primary site: abnormalities of cellular DNA content and survival.
    Hedley DW; Leary JA; Kirsten F
    Eur J Cancer Clin Oncol; 1985 Feb; 21(2):185-9. PubMed ID: 3987755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of nuclear morphometry and DNA ploidy as prognostic indicators in nonresectable adenocarcinoma of the pancreas.
    Linder S; Lindholm J; Falkmer U; Blåsjö M; Sundelin P; von Rosen A
    Int J Pancreatol; 1995 Dec; 18(3):241-8. PubMed ID: 8708396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucin-producing pancreatic tumors: a study of nuclear DNA content by flow cytometry.
    Murakami Y; Yokoyama T; Kodama T; Takesue Y; Okita M; Nakamitsu A; Imamura Y; Santo T; Tsumura H; Miyamoto K
    Surg Today; 1993; 23(6):491-5. PubMed ID: 8395265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung.
    Cibas ES; Melamed MR; Zaman MB; Kimmel M
    Cancer; 1989 Apr; 63(8):1552-6. PubMed ID: 2924263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear DNA content and clinical follow-up in resected pancreatic adenocarcinoma.
    Bui HX; Ballouk F; del Rosario A; Abdulla M; Khan M; Jennings TA; Ross JS
    Anal Quant Cytol Histol; 1993 Dec; 15(6):389-95. PubMed ID: 8297429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study.
    Zaino RJ; Davis AT; Ohlsson-Wilhelm BM; Brunetto VL
    Int J Gynecol Pathol; 1998 Oct; 17(4):312-9. PubMed ID: 9785131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flow cytometric DNA content analysis in thyroid carcinoma].
    Zuo LF
    Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):106-9. PubMed ID: 1879287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin-embedded specimens.
    Porschen R; Remy U; Bevers G; Schauseil S; Hengels KJ; Borchard F
    Cancer; 1993 Jun; 71(12):3846-50. PubMed ID: 8508352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy analysis of mucinous cystic tumors of the pancreas. Correlation of aneuploidy with malignancy and poor prognosis.
    Southern JF; Warshaw AL; Lewandrowski KB
    Cancer; 1996 Jan; 77(1):58-62. PubMed ID: 8630940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of flow cytometry for DNA content and brush cytology for detection of malignancy in pancreaticobiliary strictures.
    Ryan ME; Baldauf MC
    Gastrointest Endosc; 1994; 40(2 Pt 1):133-9. PubMed ID: 8013809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of flow cytometric and absorption cytometric DNA values as prognostic indicators for pancreatic carcinoma.
    Bose KK; Allison DC; Hruban RH; Piantadosi S; Zahurak M; Dooley WC; Lin P; Cameron JL
    Cancer; 1993 Feb; 71(3):691-700. PubMed ID: 8431848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases.
    Jones EC; McNeal J; Bruchovsky N; de Jong G
    Cancer; 1990 Aug; 66(4):752-7. PubMed ID: 2386903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.